Hana Biosciences to Present At the Rodman & Renshaw 10th Annual Healthcare Conference On November 10, 2008
November 04, 2008 07:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences to Present At the Seventh Annual Bio(r) Investor Forum
October 22, 2008 07:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
September 09, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Announces Second Quarter 2008 Results
August 11, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
Hana Biosciences to Present At the Canaccord Adams 28th Annual Global Growth Conference
August 07, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Announces Conference Call On Second Quarter Financial Results and Business Update
July 28, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 28, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will announce its...
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
July 14, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 14, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Announces Schedule Change for Presentation At the Collins Stewart 4th Annual Growth Conference
July 07, 2008 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 7, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that,...
Hana Biosciences Presents Alocrest and Menadione Data At the European Society for Medical Oncology Conference
July 07, 2008 07:05 ET
|
Talon Therapeutics, Inc.
* Alocrest(tm) Phase 1 Data Demonstrates Potential for Improved Safety
and Efficacy Compared to Conventional Vinorelbine
* Menadione Topical Lotion Restores Kinase Activity and Does Not
...
Hana Biosciences to Present At the Collins Stewart 4th Annual Growth Conference
July 02, 2008 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., July 2, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced that Steven R. Deitcher,...